At Holdings Channel, we have reviewed 958 13F filings for the 06/30/2022 reporting period, and looked at the various S&P 500 components held by each of these reporting hedge funds and other 13F filers. We added up the shares in each fund and calculated the total. Next, we went back in time to 03/31/2022 and did the same thing for each of the 958 funds. By comparing the same group across the two periods, we can see which S&P 500 components, in the aggregate, these particular funds have been buying and selling.
Bio-Rad Labatories Inc (Symbol BIO) is one of the notable components with notable buying. It is important to mention that 13F filings are not sufficient to tell the whole story. Funds are only required by law to disclose their financial information. Lang They are allowed to hold positions with the SEC but not required by law to disclose them Short positions. If a fund is making a bearish wager against a stock, such as by shorting calls and longing stock, they might also be long some stock, which would allow them to trade around their bearish position. A 13F filing could reveal this long component. Although everyone might assume that the fund has a bullish outlook, it is only one part of the story. The bearish/short sides of the position are not visible.
We believe however that looking at the bigger picture is a better way to look at things. Groups The analysis of 13F filings can prove to be a fascinating exercise, especially when you compare one holding period with another. Let’s look at the changes in BIO positions for 958 funds. We have compared the 03/31/2022 report to see the difference. Between these two periods, we found the following:
Funds increased their holdings in aggregate by 378.994 shares, from 152.761 to 531.755 For a share count growth of approximately 248.10%.
On 06/30/2022, the top three BIO-holding funds were:
We’ll continue following the latest 13F filings Fund managers, and present interesting stories that are based on a comparison of the aggregate information between managers. Although individual 13F filings may sometimes seem misleading because of the lengthy nature of the information they contain, the total sum across all the files is a good indicator. Groups The transfer of funds from one reporting period into another can be more informative and relevant. This could lead to interesting stock ideas that warrant further research, such as Bio-Rad Laboratories Inc (Symbol : BIO).
10 S&P 500 Components Hedge Funds Are Buying »
These views and opinions are solely the opinions of the author. They do not necessarily reflect the views of Nasdaq, Inc.